European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD 03/06/2025, 16:21 ansa.it 0 0
L'industria automobilistica cambia marcia: personale e tecnologia sono determinanti 03/06/2025, 16:08 ansa.it 0 0
Nessun commento